A recent study conducted between September 2022 and March 2023 explored the efficacy of peripheral nerve stimulation (PNS) in treating essential tr...
In today's fast-paced culture, where social media often disseminates distressing news and workdays seem interminable, many individuals experience c...
Recent research has investigated the acute cardiorespiratory physiological responses to functional electrically stimulated (FES) cycling in individ...
Epicrispr Biotechnologies has commenced a groundbreaking clinical trial for EPI-321, a novel gene-modulating therapy aimed at treating facioscapulo...
IGC Pharma has announced promising preclinical data on its investigational molecule IGC-M3, which targets multiple biological mechanisms central to...
Marea Therapeutics has enrolled the first patient in its Phase 2b TYDAL-TIMI 78 clinical study, which evaluates the drug MAR001 in adults at risk o...
Vertex Pharmaceuticals has announced the results of its Phase 2 study evaluating VX-993, a selective NaV1.8 pain signal inhibitor, for treating acu...
Ethris GmbH has commenced a Phase 2a clinical trial for its mRNA-based candidate ETH47, aimed at reducing asthma symptoms triggered by rhinovirus. ...
Neuralink, a company founded by Elon Musk, has initiated its first European clinical trial in the United Kingdom. The trial focuses on individuals ...
A recent study has developed a predictive model to estimate the probability of feeding intolerance (FI) in neonates with hypoxic ischemic encephalo...